World's Best Scientists 2026 revealed!
Hitomi Sezaki

Hitomi Sezaki

D-Index & Metrics

Microbiology

D-Index
56
Citations
11391
World Ranking
3701
National Ranking
147

Overview

Hitomi Sezaki is affiliated with Toranomon Hospital in Japan and has contributed extensively to medical research, particularly in the field of hepatology. Their academic work spans a range of topics focused on liver diseases, cancer treatment, and liver-related diagnostic techniques.

The main fields of study for Sezaki include Medicine, with a strong focus on subfields such as Hepatology, Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging, and Endocrinology, Diabetes and Metabolism.

The primary research topics covered in Sezaki's work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease and Transplantation
  • Pancreatic and Hepatic Oncology Research
  • MRI in Cancer Diagnosis

Sezaki has published in various scientific venues, with frequent contributions to the following journals:

  • Oncology
  • Hepatology Research
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • Kanzo

Among the recent papers authored are:

  • Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis, 2020, The Lancet. Gastroenterology & Hepatology
  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis, 2021, Med
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine
  • Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis, 2020, Liver Cancer

Sezaki's research collaborations include frequent co-authors such as Hiromitsu Kumada, Tetsuya Hosaka, Yusuke Kawamura, Norio Akuta, and Fumitaka Suzuki. These collaborative works contribute to the interdisciplinary approach spanning hepatology, oncology, and clinical medicine.

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

    Kazuaki Chayama;C. Nelson Hayes;Hiromi Abe;Daiki Miki

  • Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

    Masahiro Kobayashi;Fumitaka Suzuki;Shunichiro Fujiyama;Yusuke Kawamura

  • Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

    Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta;Yoshiyuki Suzuki

  • Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up☆

    Hiromi Yatsuji;Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta

  • Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.

    Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta;Hitomi Sezaki

  • Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies.

    Norio Akuta;Chizuru Watanabe;Yusuke Kawamura;Yasuji Arase

  • Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus

    Norio Akuta;Yusuke Kawamura;Chizuru Watanabe;Akihiro Nishimura

  • Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.

    Hitomi Sezaki;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Yasuji Arase
Yasuji Arase University of Yamanashi
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Yuzo Miyakawa
Yuzo Miyakawa Miyakawa Memorial Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in microbiology opens doors to diverse career paths, many of which can be complemented by related online degrees. For individuals with unique circumstances, such as those seeking the best associate degrees for felons, online programs offer flexible options to build skills and re-enter the workforce effectively.

Healthcare is a prominent field linked to microbiology. For example, becoming a functional medicine nurse practitioner involves advanced knowledge of biology and patient care, making it a suitable transition for microbiology graduates interested in clinical roles. Similarly, the field of medical coding provides alternative career pathways. Earning certification as a certified professional coder (CPC) allows you to work in healthcare administration, combining detail orientation with healthcare knowledge.

Another growing sector is health information management. This career requires expertise in managing patient data and health records, often supported by backgrounds in science and technology. Understanding the health information management job description and salary can help you assess if this path aligns with your career goals.

Exploring these related degrees and career options can enhance your opportunities and provide valuable alternatives within the biomedical and healthcare industries.

Best Scientists Citing Hitomi Sezaki

Trending Scientists